Search Results - "Czlonkowski, Andrzej"

Refine Results
  1. 1

    Mechanism of action of three newly registered drugs for multiple sclerosis treatment by Kasarełło, Kaja, Cudnoch-Jędrzejewska, Agnieszka, Członkowski, Andrzej, Mirowska-Guzel, Dagmara

    Published in Pharmacological reports (01-08-2017)
    “…Multiple sclerosis (MS) is a disease of suspected autoimmune origin leading to neurodegeneration. The disease pathomechanism is considered to be primarily…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease by Świątkiewicz, Maciej, Zaremba, Małgorzata, Joniec, Ilona, Członkowski, Andrzej, Kurkowska-Jastrzębska, Iwona

    Published in Pharmacological reports (2013)
    “…Parkinson's disease (PD) is one of the most common neurodegenerative diseases. An inflammatory reaction seems to be involved in the pathological process in PD…”
    Get full text
    Journal Article
  4. 4

    Neurochemical and Behavioral Characteristics of Toxic Milk Mice: An Animal Model of Wilson’s Disease by Przybyłkowski, Adam, Gromadzka, Grażyna, Wawer, Adriana, Bulska, Ewa, Jabłonka-Salach, Katarzyna, Grygorowicz, Tomasz, Schnejder-Pachołek, Anna, Członkowski, Andrzej

    Published in Neurochemical research (01-10-2013)
    “…Toxic milk mice have an inherited defect of copper metabolism. Hepatic phenotype of the toxic milk mice is similar to clinical findings in humans suffering…”
    Get full text
    Journal Article
  5. 5

    Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease by Schwenkgrub, Joanna, Joniec-Maciejak, Ilona, Sznejder-Pachołek, Anna, Wawer, Adriana, Ciesielska, Agnieszka, Bankiewicz, Krzysztof, Członkowska, Anna, Członkowski, Andrzej

    Published in Pharmacological reports (01-01-2013)
    “…Parkinson's disease (PD) is the second most common progressive neurodegenerative disorder. The degeneration of the nigro-striatal pathway has been linked with…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Influence of age and gender on cytokine expression in a murine model of Parkinson's disease by Ciesielska, Agnieszka, Joniec, Ilona, Kurkowska-Jastrzebska, Iwona, Przybyłkowski, Adam, Gromadzka, Grazyna, Członkowska, Anna, Członkowski, Andrzej

    Published in Neuroimmunomodulation (01-01-2007)
    “…The neuroinflammatory reaction has been linked with Parkinson's disease. One of the hypotheses to explain the significance of age and gender (male…”
    Get more information
    Journal Article
  9. 9

    Tryptase levels in patients after acute coronary syndromes: The potential new marker of an unstable plaque? by Filipiak, Krzysztof J., Tarchalska‐Krynska, Bozena, Opolski, Grzegorz, Rdzanek, Adam, Kochman, Janusz, Kosior, Dariusz A., Czlonkowski, Andrzej

    Published in Clinical cardiology (Mahwah, N.J.) (01-08-2003)
    “…Background: Mast cells (MCs) are multifunctional immune cells that produce a number of vasoactive or thromboactive mediators. Elevated numbers of human heart…”
    Get full text
    Journal Article
  10. 10

    The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse by Kurkowska-Jastrzębska, Iwona, Wrońska, Aneta, Kohutnicka, Małgorzata, Członkowski, Andrzej, Członkowska, Anna

    Published in Experimental neurology (01-03-1999)
    “…In degenerative disorders of the CNS an immune system involvement in the pathological process is postulated. The MPTP model of Parkinson's disease seem to be a…”
    Get full text
    Journal Article
  11. 11

    BDNF − 270 C>T polymorphisms might be associated with stroke type and BDNF − 196 G>A corresponds to early neurological deficit in hemorrhagic stroke by Mirowska-Guzel, Dagmara, Gromadzka, Grazyna, Czlonkowski, Andrzej, Czlonkowska, Anna

    Published in Journal of neuroimmunology (15-08-2012)
    “…Abstract Genetic factors might be involved in stroke prognosis, however the role of brain-derived neurotrophic factor (BDNF) in stroke recovery is unknown. We…”
    Get full text
    Journal Article
  12. 12

    Association of IL1A , IL1B, ILRN, IL6, IL10 and TNF-α polymorphisms with risk and clinical course of multiple sclerosis in a Polish population by Mirowska-Guzel, Dagmara, Gromadzka, Grazyna, Mach, Anna, Czlonkowski, Andrzej, Czlonkowska, Anna

    Published in Journal of neuroimmunology (01-07-2011)
    “…Abstract Single nucleotide polymorphisms in human pro- and anti-inflammatory genes, including IL1RN VNTR (rs315952), IL1A 4845 G > T (rs17561), L1B- 511 C > T…”
    Get full text
    Journal Article
  13. 13

    Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease by Kurkowska-Jastrzębska, Iwona, Litwin, Tomasz, Joniec, Ilona, Ciesielska, Agnieszka, Przybyłkowski, Adam, Członkowski, Andrzej, Członkowska, Anna

    Published in International immunopharmacology (01-10-2004)
    “…The pathological process of neurodegeneration, which is observed in Alzheimer's (AD) and Parkinson's (PD) diseases and that follows any insult to the central…”
    Get full text
    Journal Article
  14. 14

    Phenotyping analysis of peripheral blood leukocytes in patients with multiple sclerosis by Paź, Aleksandra, Fiszer, Urszula, Zaborski, Jacek, Korlak, Janina, Czlonkowski, Andrzej, Czlonkowska, Anna

    Published in European journal of neurology (01-05-1999)
    “…Multiple sclerosis (MS) is a central nervous disease thought to be elicited by an autoimmune process. Many studies in recent years have concentrated on finding…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Impact of BDNF -196 G>A and BDNF -270 C>T Polymorphisms on Stroke Rehabilitation Outcome: Sex and Age Differences by Mirowska-Guzel, Dagmara, Gromadzka, Grazyna, Mendel, Tadeusz, Janus-Laszuk, Barbara, Dzierka, Justyna, Sarzynska-Dlugosz, Iwona, Czlonkowski, Andrzej, Czlonkowska, Anna

    Published in Topics in stroke rehabilitation (01-01-2014)
    “…Background: Genetic factors, including gene polymorphisms, are promising in determining stroke rehabilitation outcome. Brain-derived neurotrophic factor (BDNF)…”
    Get full text
    Journal Article
  18. 18

    Influence of BDNF polymorphisms on Wilson’s disease susceptibility and clinical course by Mirowska-Guzel, Dagmara, Litwin, Tomasz, Gromadzka, Grazyna, Czlonkowski, Andrzej, Czlonkowska, Anna

    Published in Metabolic brain disease (01-09-2013)
    “…Susceptibility to Wilson’s disease (WD) and its clinical manifestations are thought to be affected by genetic factors, including polymorphisms. The role of…”
    Get full text
    Journal Article
  19. 19

    Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by Joniec, Ilona, Ciesielska, Agnieszka, Kurkowska-Jastrzebska, Iwona, Przybylkowski, Adam, Czlonkowska, Anna, Czlonkowski, Andrzej

    Published in Brain research (19-03-2009)
    “…Abstract Parkinson's disease (PD) is an age- and sex-related neurodegenerative disorder of unknown aetiology. The involvement of nitric oxide synthase (NOS) in…”
    Get full text
    Journal Article
  20. 20

    Association of MMP1 , MMP3 , MMP9 , and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population by Mirowska-Guzel, Dagmara, Gromadzka, Grazyna, Czlonkowski, Andrzej, Czlonkowska, Anna

    Published in Journal of neuroimmunology (29-09-2009)
    “…Abstract Single nucleotide polymorphisms in human MMP genes, including MMP1 (− 1637 1G > 2G), MMP3 (− 1612 5A > 6A), MMP9 (− 1562 C > T), and MMP12 (− 82 A >…”
    Get full text
    Journal Article